Ecolab Inc

ECL remains in a Stage 3 downtrend, with a decisive support failure below the 276–278 zone and follow-through selling. Price is extended below the declining EMAs and 200-day SMA, with neutral overbought/oversold conditions and no clear exhaustion, signaling further downside. Under a Stable strategy, immediate sell-side participation is warranted, ideally on a retest of the broken support near the 276–278 area for rejection-based entries.

• ↑Q2 2026 adjusted EPS rose 11% to $8.15, driven by 5% organic sales growth.
• ↑Life sciences revenue grew 15% while Ecolab Digital surged 27%, boosting margins.
• ↓Rising commodity prices strain margins despite pricing strategies.